Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00783614 · ClinicalTrials.gov registry record · Phase 2
Aspirin and Antiretroviral Therapy in HIV Infected Patients
A Phase 2 study, sponsored by Hennepin Healthcare Research Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT00783614 is a Phase 2 study that was terminated before completion, run by Hennepin Healthcare Research Institute. The registered enrollment target is 22 participants.
The verdict
NCT00783614, a Phase 2 study, was terminated before completion, sponsored by Hennepin Healthcare Research Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of HIV treatment (antiretroviral therapy) and aspirin use on risk for cardiovascular disease among HIV infected persons.
Interventions
- DRUG Aspirin 325mg
- DRUG Antiretroviral therapy (ART)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00783614
The ClinicalTrials.gov registry entry for NCT00783614 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aspirin 325mg is the first listed.
NCT00783614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00783614 about?
NCT00783614 is a clinical study titled "Aspirin and Antiretroviral Therapy in HIV Infected Patients". The purpose of this study is to examine the effects of HIV treatment (antiretroviral therapy) and aspirin use on risk for cardiovascular disease among HIV infected persons.
What is the current status of trial NCT00783614?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2008-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00783614?
The interventions under investigation include: Aspirin 325mg (DRUG), Antiretroviral therapy (ART) (DRUG).
Who is sponsoring clinical trial NCT00783614?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.